Join
Live feed
·
PRReleasevia Quantisnow
ADMA Biologics Inc logo

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance

ByQuantisnow·Wall Street's wire, on your screen.
ADMA· ADMA Biologics Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADMA (ADMA Biologics Inc) and more on Quantisnow.